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Hyperspectral analysis applied to micro-Brillouin
maps of amyloid-beta plaques in Alzheimer’s
disease brains
Francesca Palombo, *a Francesco Masia, b Sara Mattana, c
Francesco Tamagnini, d Paola Borri, e Wolfgang Langbein b and
Daniele Fioretto f
A recent investigation on the architecture and chemical composition of amyloid-β (Aβ) plaques in ex vivo
histological sections of an Aβ-overexpressing transgenic mouse hippocampus has shed light on the infrared
light signature of cell-activation related biomarkers of Alzheimer’s disease. A correlation was highlighted
between the biomechanical properties detected by Brillouin microscopy and the molecular make-up of Aβ
plaques provided by FTIR spectroscopic imaging and Raman microscopy (with correlative immunoﬂuores-
cence imaging) in this animal model of the disease. In the Brillouin spectra of heterogeneous materials such
as biomedical samples, peaks are likely the result of multiple contributions, more or less overlaid on a spatial
and spectral scale. The ability to disentangle these contributions is very important as it may give access to
discrete components that would otherwise be buried within the Brillouin peak envelope. Here, we applied
an unsupervised non-negative matrix factorization method to analyse the spontaneous Brillouin microscopy
maps of Aβ plaques in transgenic mouse hippocampal sections. The method has already been proven suc-
cessful in decomposing chemical images and is applied here for the ﬁrst time to acoustic maps acquired
with a Fabry–Perot Brillouin microscope. We extracted and visualised a decrease in tissue rigidity from the
core through to the periphery of the plaque, with spatially distinct components that we assigned to speciﬁc
entities. This work demonstrates that it is possible to reveal the structure and mechanical properties of Aβ
plaques, with details visualized by the projection of the mechanical contrast into a few relevant channels.
Introduction
Dementia is a prevalent disease, which aﬀects around
47 million people worldwide, a number that is predicted to
triple by 2050 based on current trends due to an ageing popu-
lation.1 Amyloidopathy is a major hallmark of Alzheimer’s
disease (the most common form of dementia) and consists of
abnormal deposits of the amyloid-β (Aβ) peptide in the brain
parenchyma.
There is no reliable and aﬀordable diagnostic tool for
Alzheimer’s disease in vivo. This has prompted early appli-
cations of vibrational spectroscopy and imaging techniques to
investigate the structure and molecular constituents of Aβ
plaques in the brain of both humans and mouse models of
the disease.2,3 These studies have revealed the presence in
many plaques of a lipid-rich layer surrounding a core that is
made of intermolecular β-sheet structures of the Aβ peptide.
We clarified the origin of this lipid layer in senile plaques
within ex vivo hippocampal sections of Aβ-overexpressing
TASTPM mouse brain (a model for familial Alzheimer’s
disease) using a combination of chemical imaging (FTIR spec-
troscopic imaging and Raman microscopy) and immuno-
fluorescence imaging.4 The lipid layer stained positive for astro-
cytes co-localized with the lipid-loaded ring. This was an impor-
tant result as it shows that FTIR and Raman techniques not only
are sensitive to the Aβ peptide structure and aggregation, but they
can also detect signatures of astrogliosis and possibly other bio-
markers of inflammation with potential for clinical translation.
Brillouin spectroscopy is an emerging biophotonic tech-
nique, which probes the micromechanical properties of matter
through the frequency shift of light scattered oﬀ thermally
induced acoustic waves or phonons at high frequency (GHz). It
is an optical, contactless and non-destructive technique, and
probes native signals that relate to the viscoelasticity or
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stiﬀness of matter on a micro-scale. Typically a Brillouin spec-
trum contains one or more sets of symmetric inelastic scatter-
ing peaks to the central Rayleigh line; these peaks arise from
Doppler-shifted longitudinal phonons propagating with a fre-
quency equal to the Brillouin shift.5 We applied Brillouin
microscopy to a range of biological and medical samples
including protein fibres,6–8 biofilms,9,10 live cells,11 normal
tissues6 and pathologies including pre-cancerous stages in epi-
thelial tissue12,13 and Aβ plaques in an Alzheimer’s brain.14
We found important correlations between chemical compo-
sition, structure and micromechanics, which form the basis
for further investigations on living systems and translation to
the clinics. For the first time, the micromechanical properties
of the lipid membrane in astrocyte processes surrounding Aβ
plaque cores in ex vivo sections of transgenic mouse hippo-
campus were characterised using Brillouin scattering.14
As for other spectroscopic techniques, the Brillouin peak
has two major contributions to the observed linewidth: homo-
geneous broadening (due to local viscosity aﬀecting each
mode identically) and heterogeneous broadening (arising from
mechanically heterogeneous ‘environments’ within the scatter-
ing volume). Multiple-scattering processes in turbid media
may also result in eﬀective broadening. However, due to the
few micrometres of interaction length below the sample
surface in the confocal Brillouin scattering setup used, mul-
tiple scattering can be neglected for the data presented.
Additionally, asymmetric broadening is generated by the finite
numerical aperture of collection of scattered light. In the
present data, this eﬀect is small (∼1%) due to the small NA of
the objective used, and thus does not provide a significant
broadening.14 The heterogeneous character of line broadening
in Brillouin spectra is an issue that insofar has been solved
only in the case of suﬃciently separated contributions such as
those from live cells and the buﬀer saline.11 For biomedical
applications, this is a particularly pressing issue. In Aβ
plaques for which we have demonstrated the mechanical
heterogeneity in a mouse model of amyloidopathy,4 this is
apparent as the Brillouin peak detected in the mapping mode
from any spatial location at low magnification (20×) arises
from multiple contributions from diﬀerent molecular consti-
tuents. An in-depth investigation of the molecular species
involved in the mechanism of Aβ plaque formation is the first
step to unravel the pathophysiology of this complex disease.
The aim of this work was to investigate whether it is poss-
ible to separate multiple phonon modes contributing to the
spectral band shape of the Brillouin peak in a heterogeneous
sample. We used an Aβ-overexpressing transgenic mouse
model of Alzheimer’s disease, TASTPM mice that carry a
double mutation on the amyloid precursor protein (APP) and
one single mutation on the presenilin-1 gene causing preva-
lent amyloid plaque deposition before they are six months
old.15,16 Aβ deposits within the histological sections of the
fixed brain hippocampus from TASTPM mice were analysed. In
this work, we tested a new method based on non-negative
matrix factorization (NMF)17,18 to decompose Brillouin hyper-
spectral datasets of Aβ plaques in transgenic mice hippo-
campus. In this method, the hyperspectral images are inter-
preted as a linear combination of a limited number of com-
ponents, each characterised by a spectrum and a concentration
map. Both spectra and spatial maps have a non-negativity con-
straint, hence the basis is not orthonormal. The algorithm
searches for the set of spectra and spatial distributions which
minimise the factorization error. Here we provide evidence
that distinct spatial locations within Aβ plaques – which
correspond to specific molecular species – have diﬀerential
viscoelastic properties probed by Brillouin spectroscopy. This
opens up new avenues for data analysis of micro-Brillouin
images based on chemometrics and multivariate statistics.
Results
Fig. 1 shows bright-field reflection and Brillouin images of
amyloid plaques in transgenic mouse brain sections, whereby
the plaque core is easily recognizable from the elevated fre-
quency of the Brillouin peak. This has previously been shown
to correspond to the intermolecular β-sheets of the aggregated
Aβ peptide detected by FTIR and Raman spectroscopy applied
to the same tissue sections.4
Fig. 1 (Top panel) Reﬂection optical images of plaques in transgenic
mouse brain sections containing the hippocampus. Yellow boxes indi-
cate the 66 × 60 μm2 and 50 × 43 μm2 areas of the Brillouin map of
(a) a whole plaque and (d) a quarter of a plaque. (Middle and bottom
panels) Brillouin images refer to the distribution of (b, e) frequency shift
and (c, f ) linewidth derived from DHO ﬁt analysis applied to the Brillouin
peak across the map spectra (see Methods).
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Indeed, the elevated rigidity of the plaque core observed
here can be attributed to the deposition of aggregates of
β-amyloid protein in β-pleated sheet conformation and to the
exclusion of hydration water from this highly hydrophobic
region.14 A lipid-rich layer surrounding the plaque core was
apparent in the chemical images as well as in the mechanical
maps through a depleted frequency shift (Fig. 1b and e) and
an increased linewidth (Fig. 1c and f) of the Brillouin peak.
Moving on to the factorization analysis, we note that the
only supervised parameter we have to choose is the number of
components used. It was chosen here to result in a spectral
error without an obvious remaining spatial structure (see
Fig. 2, which refers to the map of a whole plaque shown in
Fig. 1a).
The spectral error at each position is defined as the root-
mean-square of the error over the spectral points normalized
by the Frobenius norm of the measured data over these
points.17 For 2 and 3 components, the spectral error shows sig-
nificant spatial structures, both at the core and at the edge of
the plaque, indicating that there are too few components to
describe the data within its noise. By using 4 or more com-
ponents, no clear spatial structure in the error is observed.
Furthermore, the global error, defined as the ratio of the
Frobenius norms of the error and the data over all data,
decreases with increasing number of components (see Fig. 2)
and shows a significantly lower decrease adding a fifth com-
ponent compared to adding the third or fourth component.
Moreover, when using more than 4 components, the factoriz-
ation returns pairs of components which have similar spatial
distributions, indicating that the algorithm is splitting a
physically meaningful component into two. We therefore use
in the following 4 components, for which the results of
the unsupervised decomposition method are reported in Fig. 3
and 4.
The linewidths of the components resolved by the factoriz-
ation analysis are less than 5 GHz (see below), hence they are
smaller than the linewidths previously obtained by fitting each
spectrum of the maps to a single damped harmonic oscillator
(DHO) function (Fig. 1c and f). This suggests that the partially
heterogeneous nature of the Brillouin peaks can be resolved by
the hyperspectral analysis, giving a reasonable proxy for the
diﬀerent biological components of the tissue.
When comparing these results with those from the analo-
gous decomposition of vibrational spectroscopic images (e.g.
from IR and Raman microscopy techniques), we must note
that Brillouin microscopy cannot access detailed molecular
level information since it reveals collective excitations (acoustic
phonons) with frequency and linewidth given by average
mechanical properties over micrometric mean free paths.
However, heterogeneity in biological matter is expressed at
Fig. 3 (Top panel) Reﬂection optical image of a plaque in a transgenic
mouse brain section and factorisation basis spectra retrieved by NMF. (a)
Photomicrograph of the plaque with a yellow box denoting the region
of the Brillouin map. (b) Spectra of the four factorisation components.
Symbols denote the data and lines indicate the DHO ﬁt result. The com-
ponents are colour coded so that (middle and bottom panels) the
corresponding concentration maps are also presented. The four com-
ponents can be attributed (see text) to the distribution of (c) the plaque
core made of β-sheet structures, presenting a spectrum with the largest
frequency shift, (d) a ﬁrst intermediate region, (e) a second intermediate,
more diﬀuse region, and (f ) the periphery of the plaque having a broad
linewidth and small frequency shift, plausibly related to the lipid-rich
region of the astrocyte processes. The greyscale of the concentration
maps goes from 0 (black) to 1 (white). The map corresponds to a 66 ×
60 μm2 area of the specimen acquired with a step size of 1.5 μm.
Fig. 2 Factorization error of the NMF analysis applied to the map of a
whole plaque (Fig. 1a) as a function of the number of components N
used. Spatially resolved error maps for N = 2 to 6 on a greyscale as
shown, and the global error, are given.
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various length scales, and it is invaluable to be able to resolve
mechanical heterogeneities on a micrometre scale within the
scattering volume. The unsupervised factorization method
applied here is the first step in this direction, as demonstrated
by these results, which are consistent with the biochemical
composition of the plaques in terms of lineshape and intensity
distribution of the components.
For each of the two spectral datasets (Fig. 3 and 4), the line-
shape of the four components was fitted to a homogeneous
model, described by a DHO function; results in terms of peak
position and linewidth are shown in Fig. 5. It can be seen that,
in all cases, the homogeneous model gives a reasonably good
fit. The quality of the fit deteriorates for components with
spectra peaked at smaller frequencies, i.e. component 4. We
attribute this disagreement to a partial heterogeneous broad-
ening of the spectra which is not separated into diﬀerent com-
ponents by NMF. This indicates that the spatial maps do not
show suﬃcient regions of the corresponding homogeneous
constituents. Such limitations could be overcome if, within the
NMF algorithm, the component spectra would be constrained
to DHO model shapes, which is a promising avenue for future
development of the algorithm.
With regard to the assignment of the concentration images
(greyscale images in Fig. 3 and 4), a comparison with the bio-
logical composition of the tissue suggests that:
• Component 1 (Fig. 3c and 4c), the component with the
largest frequency shift, corresponding to the largest stiﬀness,
is essentially consistent with the plaque core, made of the
aggregated Aβ peptide, a hydrophobic region from which water
is excluded. The rigidity of this region can be explained in
terms of the mechanical properties of dense core plaques.
• Component 2 (Fig. 3d and 4d) is mainly distributed
around the core, in close proximity but yet in a complementary
(spatially distinct) area. This can be identified as a transition
region, plausibly including α-helical structures of the Aβ
peptide, with diﬀerent levels of aggregation, which form the
interfacial region between the largely hydrophobic plaque core
and the hydrophilic extracellular matrix (ECM) compartment.
It is expected that the physical properties of the tissue are such
that there is a gradient in solubility from the dense-core Aβ
deposits towards the outer normal tissue.
• Component 3 (Fig. 3e and 4e) extends towards the outer
layers of the plaque, hence it seems to be appropriate to ident-
ify it with the average elastic properties of the normal tissue
(ECM). Its distribution denotes a second layer around the
plaque core. Note that the scattering intensity gradually
decreases from the core through to the periphery of the plaque
owing to a decrease in thickness and/or density of the tissue.
• Component 4 (Fig. 3f and 4f) is the softest one, and is
mainly localized in the region of the lipid ring,4,14 where an
elevated (phospho)lipid signal has been associated with astro-
Fig. 4 (Top panel) Reﬂection optical image of a quarter of a plaque in a
transgenic mouse brain section and factorisation basis spectra retrieved
by NMF. (a) Photomicrographs of the plaque with a yellow box denoting
the region of the Brillouin map. (b) Spectra of the four factorisation
components. Symbols denote the data and lines indicate the DHO ﬁt
result. The components are colour coded so that (middle and bottom
panels) the corresponding concentration maps are also presented. The
four components can be attributed (see text) to the distribution of (c)
the plaque core made of β-sheet structures, presenting a spectrum with
the largest frequency shift, (d) a ﬁrst intermediate region, (e) a second
intermediate, more diﬀuse region, and (f ) the periphery of the plaque
having a broad linewidth and small frequency shift, plausibly related to
the lipid-rich region of the astrocyte processes. The greyscale of the
concentration maps goes from 0 (black) to 1 (white). The map corres-
ponds to a 50 × 43 μm2 area of the specimen acquired with a step size
of 1.5 μm.
Fig. 5 Plot of (top part) the frequency shift and (bottom part) linewidth
of the four components derived from NMF applied to the Brillouin maps
of Aβ plaques in ex vivo sections of transgenic mouse hippocampus.
Symbols are colour coded according to the components as shown in
Fig. 3 and 4. The components were ﬁtted to a DHO function and the
resulting frequency and linewidth are shown.
Paper Analyst
6098 | Analyst, 2018, 143, 6095–6102 This journal is © The Royal Society of Chemistry 2018
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
1 
N
ov
em
be
r 2
01
8.
 D
ow
nl
oa
de
d 
on
 1
/7
/2
01
9 
12
:1
4:
33
 P
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
cyte processes (i.e. membrane extensions) radially projecting
towards the plaque core. This is the component with the
largest linewidth, suggesting more pronounced viscoelastic
eﬀects. This component can be attributed to the astrocytes
and, given that the plasma membrane of astrocytes is mainly
formed by lipids in these dry tissues, the stiﬀness measured
here may essentially correspond to that of the lipid membrane
hence providing a qualitative measure of the cell membrane’s
GHz mechanical properties.
Dispersion and absorption associated with the four com-
ponents can be better seen in Fig. 5. A progressive reduction
in frequency associated with an increase in linewidth is
observed for the four components from #1 to #4, and this is
consistent for the two plaques (red-to-blue symbols).
This plot reproduces the distinctive gradual change in
physical properties going from the dense core through to the
periphery of the plaque. A gradient of frequency shift and line-
width can be interpreted based on the distinctive structure of
Aβ deposits whereby hydrophobic and hydrophilic compart-
ments do cross over. The plaque core spectrum has a narrow
peak around 18 GHz, whilst the intermediate regions show
larger linewidths and depleted frequencies, and the astrocyte
region has a linewidth that is approximately twice as large as
the core and a frequency that is reduced by a quarter. From
the frequency shift, the longitudinal elastic modulus at GHz
frequency can be derived.19 This requires that the density and
refractive index of the medium are known; generally an
approximation is applied in that the ratio ρ/n2 is fairly constant
far from electronic resonances.14 Here, by taking n = 1.36 (ref.
20) and ρ ∼ 1.0 g cm−3 and considering a 1% frequency shift
due to the finite NA of the objective used, we obtained the
elastic modulus for the distinct components of the plaque as
being approximately 12 GPa (#1), 10 GPa (#2), 9 GPa (#3), and
8 GPa (#4). These trends suggest that the decrease in measured
stiﬀness across the diﬀerent components can also be pro-
moted by a viscoelastic eﬀect, i.e. a reduction of the relaxation
time of molecular motions21 going from the core through to
the periphery of the plaque.
Discussion
Micro-Brillouin spectroscopy was used to characterize the
micromechanics of hippocampal amyloid plaques in
Aβ-overexpressing transgenic mice. The composition of such
plaques is known to be rich in intermolecular β-sheet struc-
tures of the Aβ peptide, and dense-core plaques have a distinc-
tive ‘halo’ encompassing the core that is formed by activated
astrocyte processes.4 The change in mechanical properties
across the Aβ deposits can be explained by a parallel change in
the pattern of molecular species into the brain.14 Mice of two
groups, transgenic (TASTPM) and normal control animals,
were studied. A previous in situ examination of the same
hippocampi has shown enhanced protein’s IR absorbance and
Raman scattering, indicating that plaques occurred in the
TASTPM group.4 This was corroborated by correlative immuno-
fluorescence imaging of the same hippocampi stained with
amylo-glo. An important finding supported by medical litera-
ture22 was the detection of enhanced lipid signal in the region
surrounding the plaque core that was attributed to astrocyte
processes with the use of immunohistochemical techniques.
Astrocytic activation associated with Aβ plaques has been
known for some time, however this was the first demonstration
that chemical imaging techniques can detect not only plaques
but also associated astrogliosis, which might have a protective
role limiting the development of amyloidosis-dependent cogni-
tive decline.23
Brillouin microscopy and correlative micro-Raman analysis
confirmed the heterogeneity in Aβ deposits through maps of
Brillouin frequency shift (related to stiﬀness) and linewidth
(related to apparent viscosity), which indicated that plaques
have a rigid core rich in Aβ protein with a β-pleated sheet con-
formation, a viscoelastic lipid-rich layer surrounding the core,
and an heterogeneous extracellular matrix plausibly dissemi-
nated of glial cell bodies.14 For these reasons, this micro-
mechanical method may provide an additional contrast
mechanism to detect amyloidopathy.
Here we used a new method based on non-negative matrix
factorization (NMF)17 to decompose Brillouin hyperspectral
datasets of Aβ plaques in the hippocampus of an
Aβ-overexpressing transgenic mouse. In this method, the
hyperspectral images are interpreted as a linear combination
of a limited number of components, each characterised by a
spectrum and a concentration map. We used as many com-
ponents as required to describe most of the variance in the
dataset, leaving only a randomly distributed factorisation
error. We found that distinct spatial locations within Aβ
plaques – which correspond to specific molecular species –
have diﬀerential viscoelastic properties probed by Brillouin
spectroscopy. Four components were required to describe the
data, each characterised by a spectrum with a frequency and
linewidth that change progressively when going from the core
through to the periphery of the plaque. Component 1, the one
with the largest rigidity, corresponds to the dense core made
of aggregated Aβ peptide; component 2 can be identified as a
transition region, plausibly including α-helical structures of
the Aβ peptide with diﬀerent levels of aggregation; component
3, which extends towards the outer layers of the plaque, can be
assigned to the normal tissue’s ECM; component 4 is the
softest one and is mainly consistent with the lipid-rich layer14
previously associated with astrocyte processes.4 Given that the
plasma membrane of astrocytes is mainly formed by lipids in
these dry tissues, the stiﬀness measured here may essentially
correspond to that of the lipid membrane hence providing a
qualitative measure of the cell membrane’s stiﬀness. Both
components 1 and 2 are essentially homogeneous components
with some damping, and the others (3 and 4) have some
inhomogeneity in stiﬀness which reflects a distribution in
material’s parameters.
This is an important result because distinct components of
plaques may be obscured by overlapping spectral contri-
butions, whilst the multivariate method that analyses both
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spectral and spatial distribution within a hyperspectral dataset
can retrieve the constituent components. The result may have
clinical implications. In fact, the mechanical properties of the
plaques may influence the interaction between the biologically
active, soluble components of the plaque (Aβ monomers, oligo-
mers, protofibrils and fibrils) and the surrounding tissues and
cell types, including neurons, astrocytes, microglia and endo-
cytes. This, in turn, may aﬀect how the disease progresses. In
addition, newly developed Aβ scavenging drugs aim at treating
AD by removing pathogenic amyloid species from the brain
parenchyma. Recent clinical trials of these compounds
resulted in major setbacks,24,25 pushing the AD research com-
munity to reconsider the approach towards amyloidopathy,
highlighting the need to better describe Aβ plaque complex
chemistry and physical properties. Our approach, aiming at
correlatively describing the physical and chemical properties
of the plaques, may have a critical role in providing infor-
mation on the development of novel Aβ scavenger compounds
and the assessment of their eﬃcacy.
It is noteworthy that the finite number of components used
in the factorization method gives a coarse grained picture of
the otherwise gradually varying properties of the tissue, so that
e.g. Component 2 reflects the average properties of the tran-
sition region. Also, the method applied here makes no assump-
tion on the lineshape of the single components; in a further
implementation of the algorithm, the single spectra could be
constrained to a viscoelastic model such as DHO and a set of
homogeneous components could be retrieved. We emphasize
that NMF extracts components and their spatial concentrations
in a global analysis, which is specifically useful if the material
investigated consists of a mixture of a few components. It also
allows to describe inhomogeneous distributions within the
focal volume, which create overlapping modes. In the tra-
ditional pixel-wise fitting of the spectra with a DHO model,
such a distribution of viscoelastic properties will return an
average frequency, and an overestimated broadening. Using
multiple DHO components in such a fit is possible, but tends
to be unstable. Since the NMF analysis uses all spectra in the
dataset at the same time to extract the components and
spectra, it is robust in dealing with multiple components. This
is the first time that a multivariate statistical model was
applied to Brillouin microscopy images to decompose the
hyperspectral datasets in multiple distinct components.
In these measurements, the noise is simply the square root
of the intensity, and the signal-to-noise ratio is considerably
better than that typically obtained with VIPA spectrometers,
due to the high luminosity of the FP interferometer9 and the
adopted integration time. Whilst we have demonstrated that
recent developments in scanning FP interferometers enable
sub-second time resolution,9 here we investigated fixed
samples and chose to have a very good signal-to-noise ratio to
enable a detailed spectral bandshape analysis. Multivariate
statistics can be used to analyse hyperspectral datasets
acquired at a lower signal-to-noise ratio (hence faster acqui-
sitions) and with suitably numerous datapoints. In this sense,
even maps with larger point-to-point intervals can be
exploited, hence speeding up the analysis. This has been
shown using a combination of NMF and sparse sampling for
CARS microscopy,26,27 and could be used also for Brillouin
spectroscopy to allow for high speed mapping.
In summary, the results demonstrate the potential of
Brillouin micro-spectroscopy for studying Alzheimer’s disease.
Specifically here, we have shown the application of multi-
variate analysis, which allowed the decomposition of the
highly overlapped features forming the Brillouin spectrum of
such complex specimens, and hence the recognition of
diﬀerent constituents. The results of NMF demonstrated struc-
tural motifs of the amyloid plaques that are diﬃcult to separ-
ate via univariate analysis. In particular, NMF provided evi-
dence of individual components of the tissues such as the
dense core made of aggregated β-sheets of the Aβ peptide, tran-
sition regions plausibly characterised by α-helical structures
and normal tissue, and astrocyte processes as the outermost
layer. Thus, by taking into account spatial correlations among
spectral features, multivariate analysis was able to discriminate
between diﬀerent components of the hippocampal CA1 region,
while a univariate approach showed limitations. This demon-
strated that the application of chemometric techniques allows
information to be obtained from mechanically specific data-
sets, such as those measured by Brillouin micro-spectroscopy.
Since Brillouin spectroscopy does not involve physical contact
with, and hence no mechanical interference with, the speci-
men, it is ideally suited to human in vivo applications and, as
it relies upon the propagation of longitudinal acoustic waves,
it enables applications to tissues at depth. Brillouin
microscopy with multivariate data analysis could evolve into
an important tool for routine diagnosis of Alzheimer’s disease
if suitable in vivo probes become available. Analysis of the
micromechanics of plaques might, for example, allow the
identification of those likely to be ‘protected’ by astrogliosis
and not cause clinical events.
Methods
Sample preparation
This study was carried out in accordance with UK Home Oﬃce
Guidelines and the University of Exeter Animal Welfare Ethical
Review Board. The protocol was approved by the University of
Exeter Animal Welfare Ethical Review Board. Male 12 months
old Aβ-overexpressing TASTPM (transgenic, TG) mice were
used in this study. TASTPM mice carry two mutations on the
APP gene (APPSwe K670N, M671L) and one on the presenilin
1 gene (M146V) that can be found in patients aﬀected by famil-
ial Alzheimer’s disease.15,16 Animals were housed at room
temperature under a 12 hour light cycle, and fed a normal diet
with free access to food and water ad libitum before being
sacrificed.28
Tissues were collected and sectioned as previously
described4,28 before being mounted on Raman-grade polished
calcium fluoride slides (Crystran, Poole, Dorset, UK). Two
plaques within a brain hippocampal section of a TASTPM
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mouse were analysed, and two microspectroscopic maps were
obtained.
Brillouin microscopy
Brillouin micro-spectroscopy maps were collected with a custo-
mized JRS Scientific Instruments CM-1 confocal microscope
equipped with a 532 nm laser and a Mitutoyo long working
distance 20× (NA 0.42) objective. The backscattered light from
the sample was dispersed through a (3 + 3)-pass Fabry–Perot
interferometer onto a single photon avalanche photodiode
detector.9 The spectral resolution was approximately 100 MHz.
Characteristic Brillouin peaks due to the longitudinal acoustic
wave propagation in the tissue were analysed, yielding maps
with a spatial resolution in the range of 2 μm for the lateral
and 8 μm for the axial dimension. These peaks are a proxy for
the viscoelasticity of amyloid plaques.14 Brillouin maps were
acquired in raster scanning mode with an exposure time of 90
s per point-spectrum and a step size of 1.5 μm, in the range
−30 to 30 GHz, with 5 mW laser power on the sample. GHOST
software was used for acquisition and manipulation of the
data.
Hyperspectral image analysis
For the factorisation analysis, we considered only the anti-
Stokes part of the hyperspectral images for frequencies higher
than ∼5 GHz, to suppress contributions from the Rayleigh
scattering which would aﬀect the analysis. In the case of the
whole plaque image, first we removed the cosmic rays present
in the spectra. Cosmic rays were identified as pixels where the
intensity exceeded by five times the average intensity of the
nearest neighbours. The hyperspectral images were then
denoised by using a singular value decomposition (SVD)
approach.17 In this method, noise reduction is achieved by
applying SVD on the noise-whitened data and retaining only
the decomposition components where both the left and right
singular values do not show physically meaningful spectral
and spatial features, respectively. For the plaque images, we
considered four SVD components. Finally we analysed the
denoised hyperspectral data by using NMF with four com-
ponents. The method is unsupervised as random initial
guesses for both spectra and concentration are used. To
improve the reproducibility and limit the eﬀect of the ran-
domness of the guesses, we employed the knock-out
method.18
Fit analysis
The spectra derived from NMF applied to the Brillouin maps
were fitted to a damped harmonic oscillator (DHO) function,19
arising from a viscoelastic model of homogeneous elastic
properties.
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